These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 6121770

  • 21. Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty.
    van Oosten RV, Cools AR.
    Exp Neurol; 2002 Feb; 173(2):245-55. PubMed ID: 11822888
    [Abstract] [Full Text] [Related]

  • 22. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [Abstract] [Full Text] [Related]

  • 23. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model.
    Fornaguera J, Schwarting RK, Boix F, Huston JP.
    Synapse; 1993 Feb; 13(2):179-85. PubMed ID: 7680495
    [Abstract] [Full Text] [Related]

  • 24. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG, Dziewczapolski G, Menalled LB, García MC, Agid Y, Gershanik O, Raisman-Vozari R.
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [Abstract] [Full Text] [Related]

  • 25. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J, Zhu WM, Stanic D, Finkelstein DI, Horne MH, Henderson J, Lawrence AJ, O'Connor L, Tomas D, Drago J, Horne MK.
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [Abstract] [Full Text] [Related]

  • 26. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG, Bennett JP.
    Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
    [Abstract] [Full Text] [Related]

  • 27. Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.
    Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A.
    Mov Disord; 1991 Sep; 6(4):281-7. PubMed ID: 1684638
    [Abstract] [Full Text] [Related]

  • 28. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [Abstract] [Full Text] [Related]

  • 29. The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats.
    Fang X, Sugiyama K, Akamine S, Namba H.
    Neurosci Res; 2006 Aug; 55(4):403-9. PubMed ID: 16730826
    [Abstract] [Full Text] [Related]

  • 30. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 31. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
    Quesada A, Micevych PE.
    J Neurosci Res; 2004 Jan 01; 75(1):107-16. PubMed ID: 14689453
    [Abstract] [Full Text] [Related]

  • 32. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I, Kehr J, Andbjer B, Fuxe K.
    Exp Neurol; 2000 Jul 01; 164(1):154-65. PubMed ID: 10877926
    [Abstract] [Full Text] [Related]

  • 33. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].
    Ugriumov MV.
    Usp Fiziol Nauk; 2007 Jul 01; 38(4):3-20. PubMed ID: 18064905
    [Abstract] [Full Text] [Related]

  • 34. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
    Chen MT, Morales M, Woodward DJ, Hoffer BJ, Janak PH.
    Exp Neurol; 2001 Sep 01; 171(1):72-83. PubMed ID: 11520122
    [Abstract] [Full Text] [Related]

  • 35. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
    Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-Le Goff L, Ugrumov MV.
    J Neurol Sci; 2014 May 15; 340(1-2):198-207. PubMed ID: 24768159
    [Abstract] [Full Text] [Related]

  • 36. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun 15; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 37. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
    Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE.
    J Neurosci; 2001 Sep 01; 21(17):6853-61. PubMed ID: 11517273
    [Abstract] [Full Text] [Related]

  • 38. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 39. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
    Iwata SI, Nomoto M, Fukuda T.
    Synapse; 2001 Jan 28; 39(1):16-22. PubMed ID: 11071705
    [Abstract] [Full Text] [Related]

  • 40. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 28; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.